NO962695D0 - Nye peptider som stammer fra autoantigen for anvendelse ved immunoterapi av autoimmunsykdommer - Google Patents

Nye peptider som stammer fra autoantigen for anvendelse ved immunoterapi av autoimmunsykdommer

Info

Publication number: NO962695D0
Authority: NO; Norway
Prior art keywords: autoantigen; peptides; seq; pct; autoimmune diseases
Prior art date: 1994-10-27

Application number

NO962695A

Other languages

English (en)

Other versions

NO316703B1 (no

NO962695L (no

Inventor

Anna Maria Helena Boots

Gijsbertus Francisc Verheijden

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-27

Filing date

1996-06-26

Publication date

1996-06-26

1996-06-26 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1996-06-26 Publication of NO962695D0 publication Critical patent/NO962695D0/no

1996-06-26 Publication of NO962695L publication Critical patent/NO962695L/no

2004-04-13 Publication of NO316703B1 publication Critical patent/NO316703B1/no

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
208000023275 Autoimmune disease Diseases 0.000 title abstract 2
238000009169 immunotherapy Methods 0.000 title 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 2
210000001188 articular cartilage Anatomy 0.000 abstract 2
102000043131 MHC class II family Human genes 0.000 abstract 1
108091054438 MHC class II family Proteins 0.000 abstract 1
241000699670 Mus sp. Species 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
238000003149 assay kit Methods 0.000 abstract 1
230000006378 damage Effects 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
238000002405 diagnostic procedure Methods 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Rheumatology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Rehabilitation Therapy (AREA)
Hematology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO19962695A 1994-10-27 1996-06-26 Nye peptider som stammer fra autoantigen, anvendelse derav, samt farmasoytisk og diagnostisk blanding, og diagnostisk fremgangsmate NO316703B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP94203128		1994-10-27
EP95200886		1995-04-07
PCT/EP1995/004201 WO1996013517A1 (en)	1994-10-27	1995-10-25	Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases

Publications (3)

Publication Number	Publication Date
NO962695D0 true NO962695D0 (no)	1996-06-26
NO962695L NO962695L (no)	1996-06-26
NO316703B1 NO316703B1 (no)	2004-04-13

Family

ID=26136688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19962695A NO316703B1 (no)	1994-10-27	1996-06-26	Nye peptider som stammer fra autoantigen, anvendelse derav, samt farmasoytisk og diagnostisk blanding, og diagnostisk fremgangsmate

Country Status (23)

Country	Link
US (1)	US5736507A (no)
EP (1)	EP0733065B1 (no)
JP (1)	JP3755894B2 (no)
KR (1)	KR100485979B1 (no)
CN (1)	CN1161379C (no)
AT (1)	ATE177756T1 (no)
AU (1)	AU696827B2 (no)
BR (1)	BR9506377A (no)
CA (1)	CA2173874A1 (no)
DE (1)	DE69508380T2 (no)
DK (1)	DK0733065T3 (no)
ES (1)	ES2130672T3 (no)
FI (1)	FI118472B (no)
GR (1)	GR3030296T3 (no)
HU (1)	HU218027B (no)
IL (1)	IL115744A (no)
MX (1)	MX9602495A (no)
NO (1)	NO316703B1 (no)
NZ (1)	NZ295659A (no)
PL (1)	PL183761B1 (no)
RU (1)	RU2178797C2 (no)
TR (1)	TR199501326A2 (no)
WO (1)	WO1996013517A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5843449A (en) *	1996-03-25	1998-12-01	Akzo Nobel N.V.	Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
US6881824B1 (en)	1996-04-24	2005-04-19	Akzo Nobel N.V.	Peptides suitable for use in antigen specific immunosuppressive therapy
IL120561A0 (en) *	1996-04-24	1997-07-13	Akzo Nobel Nv	Peptides suitable for use in immunosuppressive therapy
NZ334714A (en) *	1996-09-18	2000-08-25	Zetesis Spa	Liver proteins as agents against autoimmune diseases
EP0947524A1 (en) *	1998-03-30	1999-10-06	Upither B.V.	Novel peptides for the treatment of autoimmune diseases
BR9912378A (pt) *	1998-07-23	2001-04-17	Akzo Nobel Nv	Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição para diagnóstico.
WO2000004917A2 (en) *	1998-07-23	2000-02-03	Akzo Nobel N.V.	USE OF HC gp-39 IN IMMUNE DISEASES
EP1137411B1 (en) *	1998-12-09	2006-12-06	YEDA RESEARCH AND DEVELOPMENT Co. LTD.	Palladium-substituted bacteriochlorophyll derivatives and use thereof
CA2386398A1 (en) *	1999-10-18	2001-04-26	Akzo Nobel Nv	Modified peptides and peptidomimetics for use in immunotherapy
US7265208B2 (en) *	2001-05-01	2007-09-04	The Regents Of The University Of California	Fusion molecules and treatment of IgE-mediated allergic diseases
JP2006508014A (ja) *	2001-07-24	2006-03-09	イエール・ユニバーシテイ	キチナーゼおよびキチナーゼ様分子、ならびに炎症性疾患に関する方法、組成物およびキット
EP1729805A4 (en) *	2004-02-25	2008-11-26	Medimmune Inc	METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS
WO2007027748A2 (en) *	2005-08-31	2007-03-08	Medimmune, Inc.	C/clp antagonists and methods of use thereof
RU2302872C9 (ru) *	2006-06-22	2008-12-20	Общество С Ограниченной Ответственностью "Сиа Пептайдс"	Средство, нормализующее функции хрящевой ткани, и способ его получения
GB0710529D0 (en)	2007-06-01	2007-07-11	Circassia Ltd	Vaccine
NZ583362A (en)	2007-08-15	2012-06-29	Circassia Ltd	Peptide with reduced dimer formation
EP2331124A1 (en) *	2008-08-15	2011-06-15	Circassia Limited	T-cell antigen peptide from allergen for stimulation of il-10 production
ES2378870T5 (es)	2008-08-15	2016-02-03	Circassia Limited	Vacuna que comprende péptidos Amb a 1 para uso en el tratamiento de alergia a ambrosía
HRP20150317T1 (hr)	2009-02-05	2015-04-24	Circassia Limited	Peptidi trave za cjepivo
AU2010311515B2 (en) *	2009-10-27	2014-02-20	Erytech Pharma	Composition to induce specific immune tolerance
EP3344575B1 (en)	2015-09-04	2020-04-15	SQZ Biotechnologies Company	Intracellular delivery of biomolecules to cells comprising a cell wall
CA3023092A1 (en)	2016-05-03	2017-11-09	Sqz Biotechnologies Company	Intracellular delivery of biomolecules to induce tolerance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6323898A (ja) *	1986-07-16	1988-02-01	Dainippon Pharmaceut Co Ltd	新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
IL92629A0 (en) *	1989-12-10	1990-08-31	Yeda Res & Dev	Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
GB9125024D0 (en) *	1991-11-25	1992-01-22	Kirby Julian	Rheumatoid arthritus treatment
JPH07506810A (ja) *	1992-02-10	1995-07-27	デューク・ユニバーシティ	自己抗原である病原性のｔ細胞エピトープおよびｂ細胞エピトープに対する寛容性を誘導するための合成ペプチドの使用
AU4920093A (en) *	1992-09-14	1994-04-12	Brigham And Women's Hospital	Reagents and methods for treating rheumatoid arthritis
CA2164498C (en) *	1993-07-09	2007-09-11	Paul A. Price	Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices

1995
- 1995-10-24 IL IL11574495A patent/IL115744A/xx not_active IP Right Cessation
- 1995-10-25 EP EP95937008A patent/EP0733065B1/en not_active Expired - Lifetime
- 1995-10-25 AT AT95937008T patent/ATE177756T1/de not_active IP Right Cessation
- 1995-10-25 KR KR1019960702711A patent/KR100485979B1/ko not_active Expired - Fee Related
- 1995-10-25 HU HU9601401A patent/HU218027B/hu not_active IP Right Cessation
- 1995-10-25 PL PL95315198A patent/PL183761B1/pl not_active IP Right Cessation
- 1995-10-25 CA CA002173874A patent/CA2173874A1/en not_active Abandoned
- 1995-10-25 NZ NZ295659A patent/NZ295659A/en unknown
- 1995-10-25 JP JP51430696A patent/JP3755894B2/ja not_active Expired - Fee Related
- 1995-10-25 ES ES95937008T patent/ES2130672T3/es not_active Expired - Lifetime
- 1995-10-25 US US08/619,645 patent/US5736507A/en not_active Expired - Fee Related
- 1995-10-25 BR BR9506377A patent/BR9506377A/pt not_active Application Discontinuation
- 1995-10-25 MX MX9602495A patent/MX9602495A/es not_active IP Right Cessation
- 1995-10-25 DE DE69508380T patent/DE69508380T2/de not_active Expired - Fee Related
- 1995-10-25 WO PCT/EP1995/004201 patent/WO1996013517A1/en not_active Ceased
- 1995-10-25 DK DK95937008T patent/DK0733065T3/da active
- 1995-10-25 AU AU39252/95A patent/AU696827B2/en not_active Ceased
- 1995-10-25 CN CNB951909444A patent/CN1161379C/zh not_active Expired - Fee Related
- 1995-10-25 RU RU96115937/04A patent/RU2178797C2/ru not_active IP Right Cessation
- 1995-10-27 TR TR95/01326A patent/TR199501326A2/xx unknown
1996
- 1996-06-25 FI FI962619A patent/FI118472B/fi active IP Right Grant
- 1996-06-26 NO NO19962695A patent/NO316703B1/no unknown
1999
- 1999-05-21 GR GR990401382T patent/GR3030296T3/el unknown

Also Published As

Publication number	Publication date
PL183761B1 (pl)	2002-07-31
ES2130672T3 (es)	1999-07-01
EP0733065B1 (en)	1999-03-17
WO1996013517A1 (en)	1996-05-09
ATE177756T1 (de)	1999-04-15
HUT74847A (en)	1997-02-28
IL115744A0 (en)	1996-01-19
AU3925295A (en)	1996-05-23
KR960705848A (ko)	1996-11-08
AU696827B2 (en)	1998-09-17
HU218027B (hu)	2000-05-28
IL115744A (en)	2000-07-16
NZ295659A (en)	1998-02-26
CA2173874A1 (en)	1996-05-09
RU2178797C2 (ru)	2002-01-27
BR9506377A (pt)	1997-09-16
FI962619L (fi)	1996-06-25
NO316703B1 (no)	2004-04-13
CN1161379C (zh)	2004-08-11
TR199501326A2 (tr)	1996-06-21
DK0733065T3 (da)	1999-10-11
DE69508380D1 (de)	1999-04-22
DE69508380T2 (de)	1999-09-09
MX9602495A (es)	1997-05-31
GR3030296T3 (en)	1999-09-30
FI962619A0 (fi)	1996-06-25
KR100485979B1 (ko)	2006-01-27
EP0733065A1 (en)	1996-09-25
FI118472B (fi)	2007-11-30
JPH09507861A (ja)	1997-08-12
HU9601401D0 (en)	1996-07-29
NO962695L (no)	1996-06-26
US5736507A (en)	1998-04-07
CN1168677A (zh)	1997-12-24
JP3755894B2 (ja)	2006-03-15
HK1002012A1 (en)	1998-07-24
PL315198A1 (en)	1996-10-14

Publication	Publication Date	Title
NO962695L (no)	1996-06-26	Nye peptider som stammer fra autoantigen for anvendelse ved immunoterapi av autoimmunsykdommer
Ugrinovic et al.	1997	A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis
Taneja et al.	1999	HLA class II transgenic mice as models of human diseases
TR199802082T2 (xx)	2000-09-21	Otoantigen ve otoim�n hastal�klar�n im�noterapisinde kullan�lmak i�in otoantigen yap�sal olarak ili�kili proteinler.
JP3386614B2 (ja)	2003-03-17	抗原特異的活性化ｔリンパ球、その検出及び使用
ATE252640T1 (de)	2003-11-15	Verbindungen zur immunotherapie und diagnose von tuberkulose
CY1109837T1 (el)	2014-09-10	Διαγνωστικο και θεραπευτικο επιτοπιο
NZ332427A (en)	2000-03-27	Peptides suitable for use in antigen specific immunosuppressive therapy
Monneaux et al.	2001	Key sequences involved in the spreading of the systemic autoimmune response to spliceosomal proteins
ATE248602T1 (de)	2003-09-15	Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien
Choudhury et al.	2023	Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool
ATE185151T1 (de)	1999-10-15	Neue peptide zur verwendung bei behandlung von durch t-zellen vermittelter knorpelzerstörungin autoimmunkrankheiten
Dayan et al.	1993	T cells involved in human autoimmune disease are resistant to tolerance induction.
TR200100175T2 (tr)	2001-09-21	Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
Myers et al.	2002	Immunogenicity of recombinant type IX collagen in murine collagen‐induced arthritis
Benacerraf	1993	Biological function of HLA molecules
Buus et al.	1990	The Interaction between MHC Class II Molecules and Immunogenic Peptides
Qian et al.	2005	of March 2, 2014.